A patient with decompensated cirrhosis and signs of hepatic encephalopathy is admitted to the hospital. Which of the following nursing interventions is a priority to help manage the patient's hepatic encephalopathy?

A) Administer lactulose as prescribed to reduce ammonia levels.

B) Encourage a high-protein diet to improve nutritional status.

C) Provide opioid medication for abdominal pain management.

D) Restrict fluid intake to manage ascites.

A patient with decompensated cirrhosis and hepatic encephalopathy is admitted to the hospital. Which of the following nursing interventions is most appropriate to help manage the patient's hepatic encephalopathy?

A) Administering lactulose as prescribed to reduce ammonia levels.

B) Encouraging the patient to consume a high-protein diet to maintain nutritional status.

C) Providing aspirin to manage pain and reduce liver inflammation.

D) Restricting fluid intake to manage ascites.

A patient with cirrhosis and ascites is being treated for hepatic encephalopathy with lactulose and diuretics for fluid management. After showing initial improvement, the patient now exhibits signs of infection and is diagnosed with spontaneous bacterial peritonitis (SBP). Which nursing intervention is most critical in managing this patient's new complication?

C) Initiating intravenous antibiotic therapy immediately

A) Administering antipyretics to manage fever

B) Monitoring and recording daily weights

C) Initiating intravenous antibiotic therapy immediately

D) Increasing the dose of spironolactone to enhance diuresis

A patient with cirrhosis and ascites is being treated for hepatic encephalopathy and has developed signs of spontaneous bacterial peritonitis (SBP). Which nursing intervention is most important to prioritize to prevent further complications?

B) Monitor the patient's abdominal girth and daily weight closely.

A) Encourage the patient to ambulate frequently to prevent blood clots.

B) Monitor the patient's abdominal girth and daily weight closely.

C) Restrict fluid intake to manage fluid overload effectively.

D) Administer lactulose to maintain regular bowel movements.

A patient with liver cirrhosis has developed spontaneous bacterial peritonitis (SBP) and laboratory findings indicate impaired hepatic function. As the nurse evaluates the patient's condition, which intervention should be prioritized to address the patient's current clinical needs?

A) Administer intravenous albumin to support intravascular volume and renal function

B) Increase diuretic dosage to manage ascites and reduce fluid overload

C) Initiate a high-protein diet to counteract hypoalbuminemia

D) Prepare the patient for immediate liver transplantation evaluation

A patient with liver cirrhosis is experiencing a deterioration in hepatic function and has been diagnosed with spontaneous bacterial peritonitis (SBP). The nurse is reviewing the patient's current plan of care. Which intervention should the nurse prioritize to address the patient's declining serum albumin levels and support renal function?

A) Increase the dose of diuretics

D) Encourage increased oral fluid intake

A patient with worsening hepatic encephalopathy is being treated with lactulose and a low-protein diet. The healthcare team is considering a transjugular intrahepatic portosystemic shunt (TIPSS) procedure. Which clinical finding would most likely prompt the team to proceed with the TIPSS procedure?

A) Persistent mild confusion despite optimal medical management

B) Decrease in serum albumin with increased ascites formation

D) Elevated heart rate at 112 beats per minute

A patient with hepatic encephalopathy is experiencing worsening symptoms, including mild confusion, disorientation, and elevated serum ammonia levels. Which nursing intervention is the most appropriate to include in the care plan to address these symptoms?

B) Administer lactulose as prescribed to reduce ammonia levels

A) Encourage a high-protein diet to promote healing

B) Administer lactulose as prescribed to reduce ammonia levels

C) Increase fluid intake to promote diuresis and reduce ascites

D) Initiate a high-calorie diet to meet nutritional needs

A patient with hepatic encephalopathy and worsening portal hypertension is being managed by the healthcare team. The team is considering adjusting the fluid management strategy due to increased ascites and impaired liver synthetic function. Which nursing intervention is most appropriate to prioritize in this situation?

C) Performing frequent neurological assessments to monitor mental status changes

A) Administering additional diuretics to aggressively reduce ascites

B) Monitoring for signs of variceal bleeding and preparing for emergency intervention

C) Performing frequent neurological assessments to monitor mental status changes

D) Encouraging increased oral fluid intake to support fluid balance

A patient with worsening hepatic encephalopathy and portal hypertension presents with increased ascites and a low-grade fever. The healthcare team is considering further interventions to manage the patient's condition. Which nursing intervention should be prioritized to address the risk of variceal bleeding in this patient?

D) Monitor vital signs and assess for signs of bleeding, such as hypotension and tachycardia.

A) Administer lactulose as ordered to reduce ammonia levels.

B) Educate the patient about the importance of a low-sodium diet.

C) Prepare the patient for a possible Transjugular Intrahepatic Portosystemic Shunt (TIPSS) procedure.

D) Monitor vital signs and assess for signs of bleeding, such as hypotension and tachycardia.

hepatitis B - Nursing Case Study

Pathophysiology

• Primary mechanism: Hepatitis B virus (HBV) invades hepatocytes, the liver cells, leading to an immune-mediated response. The immune system's cytotoxic T-cells target and destroy infected hepatocytes, causing liver inflammation and damage.

• Secondary mechanism: The virus's surface antigen (HBsAg) persists in the bloodstream, which can lead to chronic infection. This chronic state results in continuous immune activation and inflammation, contributing to progressive liver damage and fibrosis.

• Key complication: If unchecked, chronic hepatitis B can lead to cirrhosis, characterized by extensive scarring of the liver tissue, and increases the risk of developing hepatocellular carcinoma, a primary liver cancer.

Patient Profile

Demographics:

45-year-old male, construction worker

History:

• Key past medical history: Chronic hepatitis B infection diagnosed 5 years ago, hypertension

• Current medications: Tenofovir, Lisinopril

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Increasing fatigue and abdominal discomfort

• Key symptoms: Jaundice, nausea, decreased appetite, dark urine, mild ascites

• Vital signs: Blood pressure 140/90 mmHg, heart rate 96 bpm, respiratory rate 20 breaths per minute, temperature 37.8°C

Section 1

As the nursing team conducts an initial assessment of the patient, several concerning findings emerge. On physical examination, the patient exhibits pronounced jaundice, noticeable not only in the sclera but also in the skin. The abdominal examination reveals a distended abdomen with shifting dullness, indicating the presence of ascites, and mild tenderness in the right upper quadrant. The patient's mental status is slightly altered, exhibiting mild confusion, which raises concern for possible hepatic encephalopathy.

Laboratory results return and provide further insight into the patient's condition. The liver function tests show elevated levels of bilirubin at 4.5 mg/dL (normal range 0.1-1.2 mg/dL), ALT at 120 U/L (normal range 7-56 U/L), and AST at 98 U/L (normal range 10-40 U/L). The patient's albumin level is reduced at 2.8 g/dL (normal range 3.5-5.0 g/dL), and the prothrombin time is prolonged at 18 seconds (normal range 11-13.5 seconds), indicating impaired liver synthetic function. Ultrasound imaging of the abdomen confirms the presence of liver cirrhosis with nodular liver architecture and moderate ascites.

These findings suggest a progression of the chronic hepatitis B infection to decompensated cirrhosis. The patient's altered mental status, alongside laboratory evidence of liver dysfunction, indicates the development of hepatic encephalopathy, a complication requiring prompt intervention. The healthcare team must now consider strategies to manage ascites, address potential triggers of hepatic encephalopathy, and prevent further liver damage. These interventions will be critical in stabilizing the patient and improving his clinical status, leading to the next steps in his treatment plan.

Section 2

As the healthcare team initiates interventions to address the patient's condition, they focus on managing the ascites and hepatic encephalopathy. The patient is placed on a low sodium diet and started on diuretics, specifically spironolactone and furosemide, to help reduce fluid accumulation. Lactulose is administered to help lower ammonia levels and mitigate the symptoms of hepatic encephalopathy. The team closely monitors the patient's mental status and fluid balance, noting any changes that could indicate a response to treatment or further complications.

After 48 hours of intervention, the patient's mental status shows some improvement, with reduced confusion and increased orientation to time and place. However, new complications arise as the patient develops signs of infection, a common risk in patients with cirrhosis and ascites. The patient's temperature rises to 101.3°F (38.5°C), and his white blood cell count increases to 14,000/mm³ (normal range 4,000-11,000/mm³), suggesting the onset of spontaneous bacterial peritonitis (SBP). The healthcare team promptly initiates empirical antibiotic therapy with intravenous cefotaxime, considering the high risk of SBP in this clinical scenario.

The emergence of infection underscores the need for vigilant monitoring and the importance of addressing potential complications swiftly. The patient's vital signs, including blood pressure, heart rate, and respiratory rate, remain stable, providing a window of opportunity for the antibiotics to take effect. The team prepares for potential adjustments in the treatment plan, recognizing that infection control and continued management of hepatic encephalopathy and ascites are crucial to stabilizing the patient's condition and preventing further deterioration.

Section 3

As the healthcare team continues to manage the patient's condition, they decide to focus on the new diagnostic results to assess the effectiveness of the current interventions and identify any further complications. Laboratory tests reveal that the patient's serum albumin level has decreased to 2.5 g/dL (normal range 3.5-5.0 g/dL), reflecting a worsening of the liver's synthetic function. Additionally, the liver function tests indicate an increase in bilirubin to 3.2 mg/dL (normal range 0.1-1.2 mg/dL) and a rise in ALT and AST levels to 120 U/L and 130 U/L respectively, suggesting ongoing liver injury. These findings, in conjunction with the development of SBP, signal a deterioration in the patient's hepatic function.

The abdominal ultrasound performed to evaluate the extent of ascites reveals moderate fluid accumulation, but no signs of bowel perforation or other acute abdominal processes. Paracentesis is conducted to analyze the ascitic fluid, confirming a polymorphonuclear leukocyte count of 350 cells/mm³, supporting the diagnosis of spontaneous bacterial peritonitis. With these results, the healthcare team reflects on the need to adjust the treatment plan to address not only the infection but also the liver's declining synthetic capacity, possibly considering albumin infusion to improve intravascular volume and support renal function.

The healthcare team remains vigilant, recognizing the delicate balance required in managing the patient's fluid status, infection, and hepatic encephalopathy. They continue to monitor the patient's response to antibiotics and diuretics, ensuring that vital signs remain stable and mental status does not regress. These ongoing assessments are crucial in determining the next steps, including the potential need for additional interventions such as a TIPSS procedure or evaluation for liver transplantation, should the patient's condition not improve with current therapies.

Section 4

As the healthcare team continues to monitor the patient's response to ongoing interventions, they observe a change in the patient’s status, which necessitates further evaluation. The patient, previously alert and oriented, now exhibits mild confusion and disorientation, suggesting a potential worsening of hepatic encephalopathy. Vital signs reveal a slight hypotension with a blood pressure of 95/60 mmHg, heart rate at 112 beats per minute, and a low-grade fever of 100.4°F. The decrease in serum albumin and the presence of ascites, coupled with these clinical signs, prompt the team to reassess the patient's fluid management strategy, considering the delicate balance between diuresis and maintaining adequate circulatory volume.

In addressing the suspected hepatic encephalopathy, the team evaluates the patient's ammonia levels, noting an increase to 80 µmol/L (normal range 15-45 µmol/L), which corroborates the clinical picture. Lactulose is administered to help reduce ammonia absorption in the gut, and the team carefully monitors mental status for any signs of improvement. They also initiate a low-protein diet to minimize ammonia production while ensuring adequate nutrition to support the patient's overall condition.

These developments prompt the team to consider more aggressive interventions, such as evaluating the necessity of a transjugular intrahepatic portosystemic shunt (TIPSS) procedure to alleviate portal hypertension and potentially improve liver function. Given the patient's deteriorating condition and ongoing complications, discussions about liver transplantation are revisited, highlighting the need for an interdisciplinary approach in managing this complex case. Throughout this process, continuous monitoring and dynamic adjustments to the treatment plan remain critical to ensure the best possible outcomes for the patient.

Section 5

As the healthcare team proceeds with the management of the patient's hepatic encephalopathy and related complications, further diagnostic evaluations are conducted, providing new insights into the patient's condition. A recent abdominal ultrasound reveals an increase in ascites, with moderate splenomegaly and signs of worsening portal hypertension. Additionally, liver function tests show further elevation of liver enzymes, with AST at 150 U/L and ALT at 130 U/L, indicating ongoing hepatic inflammation and damage. Coagulation profiles demonstrate an increased INR of 1.8, suggesting impaired synthetic function of the liver. These findings emphasize the liver's deteriorating capacity to manage the physiological demands placed upon it.

In light of these developments, the team re-evaluates the patient's fluid management strategy. Diuretics are cautiously adjusted to manage the ascites without exacerbating hypotension. Albumin infusions are considered to improve oncotic pressure and support circulatory volume. The patient's mental status remains a key focus, with frequent assessments revealing slight but inconsistent improvements in orientation and coherence following lactulose administration. Neurological evaluations are performed to rule out other possible causes of confusion, such as electrolyte imbalances or infection, given the patient's low-grade fever.

Despite these interventions, the patient's overall condition remains fragile, and the risk of variceal bleeding due to portal hypertension becomes a pressing concern. The team deliberates on the timing and appropriateness of a TIPSS procedure, weighing the potential benefits against the risks in the context of the patient's current status. As discussions about liver transplantation continue, the healthcare team emphasizes the need for a comprehensive, coordinated approach, involving hepatologists, transplant surgeons, and palliative care specialists, to address the complex and evolving needs of the patient.